Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Does neoadjuvant FOLFOX chemotherapy improve the prognosis of high-risk Stage II and III colon cancers? Three years' follow-up results of the PRODIGE 22 phase II randomized multicentre trial.
Karoui M, Gallois C, Piessen G, Legoux JL, Barbier E, De Chaisemartin C, Lecaille C, Bouche O, Ammarguellat H, Brunetti F, Prudhomme M, Regimbeau JM, Glehen O, Lievre A, Portier G, Hartwig J, Goujon G, Romain B, Lepage C, Taieb J; for PRODIGE 22 investigators/Collaborators. Karoui M, et al. Colorectal Dis. 2021 Jun;23(6):1357-1369. doi: 10.1111/codi.15585. Epub 2021 Mar 10. Colorectal Dis. 2021. PMID: 33580623 Clinical Trial.
Respiratory outcomes and survival after unplanned extubation in the NICU: a prospective cohort study from the SEPREVEN trial.
Yager H, Tauzin M, Durrmeyer X, Todorova D, Storme L, Debillon T, Casagrande F, Jung C, Audureau E, Layese R, Caeymaex L; SEPREVEN Study Group. Yager H, et al. Arch Dis Child Fetal Neonatal Ed. 2024 Apr 18:fetalneonatal-2023-326679. doi: 10.1136/archdischild-2023-326679. Online ahead of print. Arch Dis Child Fetal Neonatal Ed. 2024. PMID: 38636983
Incorporating functional genomics into the pathology-supported genetic testing framework implemented in South Africa: A future view of precision medicine for breast carcinomas.
Christowitz C, Olivier DW, Schneider JW, Kotze MJ, Engelbrecht AM. Christowitz C, et al. Among authors: olivier dw. Mutat Res Rev Mutat Res. 2024 Jan-Jun;793:108492. doi: 10.1016/j.mrrev.2024.108492. Epub 2024 Apr 15. Mutat Res Rev Mutat Res. 2024. PMID: 38631437 Free article. Review.
[Improving pre-emptive access to the kidney transplant waiting list between 2017 and 2021: Assessment of a regional program in Aquitaine].
Mathilde PR, Karine M, Frederic J, Eric A, Grégoire R, Jean-Christophe B, Savva A, Cécile D, Noëlle B, Arlette C, Brigitte B, Benjamin D, Olivier D, Xabina L, Hannah K, Karen L, Pierre M, Lionel C. Mathilde PR, et al. Among authors: olivier d. Nephrol Ther. 2024 Jan 30;20(1):1-10. doi: 10.1684/ndt.2024.64. Online ahead of print. Nephrol Ther. 2024. PMID: 38287662 French.
Validation of a brief screener for broad-spectrum mental and substance-use disorders in South Africa.
Stockton MA, Mazinyo EW, Mlanjeni L, Nogemane K, Ngcelwane N, Sweetland AC, Basaraba CN, Bezuidenhout C, Sansbury G, Lovero KL, Olivier D, Grobler C, Wall MM, Medina-Marino A, Nobatyi P, Wainberg ML. Stockton MA, et al. Among authors: olivier d. Glob Ment Health (Camb). 2023 Dec 21;11:e4. doi: 10.1017/gmh.2023.89. eCollection 2024. Glob Ment Health (Camb). 2023. PMID: 38283876 Free PMC article.
Current Perspectives on Data Sharing and Open Science in Pharmacogenomics.
Miao DNR, Ladha F, Lyle SM, Olivier DW, Ahmed S, Drögemöller BI. Miao DNR, et al. Among authors: olivier dw. Clin Pharmacol Ther. 2024 Mar;115(3):408-411. doi: 10.1002/cpt.3115. Epub 2023 Dec 13. Clin Pharmacol Ther. 2024. PMID: 38087986 No abstract available.
140 results